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Hamstring contractures in children with spastic cerebral
palsy result from a stiffer extracellular matrix
and increased in vivo sarcomere length
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Non-technical summary Muscle spasticity, due to an upper motoneuron lesion, often leads to
muscle contractures that limit range of motion and cause increased muscle stiffness. However,
the elements responsible for this muscle adaption are unknown. Here we show that muscle tissue
is stiffer in contracture compared to age-matched children, implicating the extracellular matrix
(ECM). However, titin, the major load-bearing protein within muscle fibres, is not altered in
contracture, and individual fibre stiffness is unaltered. Increased ECM stiffness is even more
functionally significant given our finding of long in vivo sarcomeres which leads tomuch larger in
vivo forces in muscle contracture. These results may lead to novel therapeutics for treating spastic
muscle contracture.
Abstract Cerebral palsy (CP) results fromanuppermotoneuron (UMN) lesion in the developing
brain. Secondary to theUMNlesion,which causes spasticity, is a pathological response bymuscle –
namely, contracture. However, the elements within muscle that increase passive mechanical
stiffness, and therefore result in contracture, are unknown. Using hamstring muscle biopsies
from pediatric patients with CP (n= 33) and control (n= 19) patients we investigated passive
mechanical properties at theprotein, cellular, tissue andarchitectural levels to identify the elements
responsible for contracture. Titin isoform, the major load-bearing protein within muscle cells,
was unaltered in CP. Correspondingly, the passive mechanics of individual muscle fibres were
not altered. However, CP muscle bundles, which include fibres in their constituent ECM, were
stiffer than control bundles. This corresponded to an increase in collagen content of CP muscles
measured by hydroxyproline assay and observed using immunohistochemistry. In vivo sarcomere
length of CP muscle measured during surgery was significantly longer than that predicted for
control muscle. The combination of increased tissue stiffness and increased sarcomere length
interact to increase stiffness greatly of the contracture tissue in vivo. These findings provide
evidence that contracture formation is not the result of stiffening at the cellular level, but stiffening
of the ECM with increased collagen and an increase of in vivo sarcomere length leading to higher
passive stresses.
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Introduction
Cerebral palsy (CP) describes a spectrum of movement
disorders caused by upper motoneuron (UMN) lesions
that occur in the developing brain (Rosenbaum et al.
2007). CP is the most common childhood movement
disorder with a prevalence of 3.6 cases per 1000 in the
US (Yeargin-Allsopp et al. 2008). Although the primary
UMN insult is not progressive, the resulting muscle
pathology does progress (Kerr Graham & Selber, 2003).
Pathological muscle in CP is described as spastic, which is
a velocity-dependent resistance to stretch due to reduced
inhibition of the stretch reflexes (Crenna, 1998). Despite
best clinical practices, children with CP often develop
contractures that limit their range of motion, decrease
their mobility andmay be painful.Whilemuscle spasticity
and hyper-activity are commonly seen in cerebral palsy,
contracture represents a unique muscle adaptation in
which the muscle increases passive stiffness such that
range of motion around a joint is limited without active
force production of themuscle. Thus,muscle contractures
represent a major disability to those affected by CP in
particular and those with UMN lesions in general (Bache
et al. 2003).
The skeletal muscle mechanism by which spasticity
results in contracture is not known. Transcriptional data
suggestmany physiological pathways are altered in contra-
cture (Smith et al. 2009). One consistent finding is that
spastic muscles from children with CP are weaker than
those of typically developing control children due to
a combination of decreased neuronal drive, decreased
muscle size and decreased specific tension (Elder et al.
2003; Rose & McGill, 2005; Stackhouse et al. 2005).
Previous studies also demonstrated that increased
resistance to stretch in spastic muscle has both an active
and passive component (Sinkjaer & Magnussen, 1994;
Mirbagheri et al. 2001; Lorentzen et al. 2010). However,
the passive elements responsible for this increased stiffness
have not been identified and these presumably represent
the therapeutic targets of physical therapy (Wiart et al.
2008), surgery (Beals, 2001) and neurotoxin injection
(Lukban et al. 2009). To date, these treatments do not
prevent contracture formation (Tilton, 2006).
It should be noted that the term ‘contracture’ is typically
referred to in the muscle physiology literature as an
increase in tension of isolatedmuscles or fibres in response
to external activation by caffeine or potassium (Savage
& Atanga, 1988). Caffeine induces calcium release from
the sarcoplasmic reticulum and potassium depolarizes
the muscle as methods to activate the crossbridge cycle
that produces muscle active tension (Conway & Sakai,
1960;Hodgkin&Horowicz, 1960).However, the common
clinical use of the term ‘contracture’ does not refer to
such activation. Rather, a clinical ‘contracture’ represents
a condition where a muscle becomes extremely stiff,
limiting range of motion, perhaps causing pain, and
deforming joints. These contractures often result from
upper motoneuron lesions such as those that occur
after stroke, head injury or cerebral palsy and represent
tremendous challenges to treat (O’Dwyer et al. 1996;
Farmer & James, 2001). Often, clinical contractures result
from chronic activation of a muscle, referred to as
‘spasticity’ and the net result is a stiff muscle that limits
the range of motion around a joint in the absence of any
active component of crossbridge cycling (Fergusson et al.
2007).
As muscle architecture is the most important
determinant of muscle force-generating capacity and
excursion, previous studies have sought to describe the
macroscopic structural adaptation of muscle in CP. It has
been suggested that contracture results from shortened
muscles and thus multiple studies have used ultrasound
technology to measure fascicle length in contractured
muscle and, while these experiments confirm reduced
CP muscle volume, evidence for shortened fascicles is
inconclusive (Shortland et al. 2002; Malaiya et al. 2007;
Mohagheghi et al. 2007, 2008). A major drawback of
ultrasound studies is that there is no normalization of
fascicle length to sarcomere length so it is conceivable
that a CP muscle and control muscle could have exactly
the same fascicle lengths, yet have different numbers
of sarcomeres in series and correspondingly different
functional mechanical properties. This would be invisible
to the ultrasound method. Direct measurement of
intraoperative sarcomere length revealed that sarcomere
lengths are indeed longer in CP muscle, suggesting
increased passive stiffness (Lieber & Friden, 2002; Ponten
et al. 2007).
Another proposed mechanism for increased passive
stiffness in contractured muscle involves alteration of the
tissue itself. Previous studies demonstrated that individual
fibres from contractured muscles are stiffer than controls,
indicating an alteration within the muscle cell (Friden
& Lieber, 2003). This increased stiffness from within the
fibre was hypothesized to arise from titin, considered the
major passive load-bearing protein within the muscle
fibre (Prado et al. 2005). Further studies confounded
this result showing that bundles of fibres, which include
extracellular matrix (ECM), from contractured muscles
were more compliant compared to controls, and thus
unable to explain the increased stiffness on the whole
muscle scale (Lieber et al. 2003). A drawback of our
previous mechanical studies is that they studied a variety
of human muscles, and we have since shown that
healthy human muscles have different passive mechanical
properties (Ward et al. 2009b) as was shown for rabbit
muscle (Prado et al. 2005).
To avoid complications that arise when making
comparisons across different muscles, we have taken
advantage of the fact that children who are undergoing
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Table 1. Patient parameters
Group N Age Sex GMFCS Popliteal angle Pass Mech N SL OH-Pro MyHC Titin
Control 19 15.8 ± 1.8 8 M
11 F
N/A N/A 14 N/A 12 6 6
CP 33 9.6 ± 4.2 23 M
10 F
I(2),II(13),III(2),
IV(6),V(10)
114 ± 15 17 11 12 6 6
Patient parameters for the control and CP groups; control patients do not have Gross Motor Function Classification System (GMFCS;
Palisano et al. 1997) or popliteal angle measurements. The right columns are the number of subjects whose biopsies were used in
the various analysis; many biopsies were used for multiple analysis: passive mechanics sample size (Pass Mech N), in vivo sarcomere
length (SL), hydroxyproline (OH-pro), myosin heavy chain biopsy analysis (MyHC) and titin biopsy analysis (Titin).
anterior cruciate ligament (ACL) reconstruction with
a hamstring autograft have muscle trimmed from the
tendon graft that can be harvested and directly compared
to the same hamstring muscles from children with CP
undergoing surgery. We hypothesized that the passive
mechanical properties of spastic muscle are altered in CP
and that this could arise across the levels of: protein (titin),
cellular (fibre), tissue (fibre bundle including ECM),
and/or architecture (sarcomere length). This work will
provide further insight into the debilitating mechanism
of muscle contracture and drive research on targeted
therapies to treat contractures.
Methods
Muscle biopsy collection
Ethical approval for this study conformed to the standards
of the Declaration of Helsinki and was approved by the
Institutional Review Board of the University of California,
San Diego Human Research Protection Program. After
obtaining consent from parents and age-appropriate
assent from children, subjects with CP (n= 33) were
recruited for this study because they were undergoing
hamstring lengthening surgery that involved gracilis and
semitendinosus muscles. Control children (n= 19) with
no history of neurological disorder were recruited because
they were undergoing ACL reconstructive surgery with
a hamstring autograft using gracilis and semitendinosus
tendons that were excised along with a portion of muscle
that could be obtained as it was trimmed from the tendon.
All patientswithCPhaddeveloped a contracture requiring
surgery, despite receiving conservative treatment. Patients
were classified based on clinical measures of the Gross
Motor Function Classification System (Palisano et al.
1997), popliteal angle, limbs affected and treatment
measures of previous surgical lengthening or botulinum
toxin injection (Table 1). Muscle biopsies were obtained
and either snap frozen in isopentane chilled by liquid
nitrogen (−159◦C), and stored at −80◦C, or placed
in glycerinated muscle relaxing solution and stored at
−20◦C.
In vivo sarcomere lengths
Custom muscle biopsy clamps, modified for pediatric
use with 0.5 cm jaw spacing were used to determine in
vivo sarcomere length (Fig. 1). We previously validated
this method against intraoperative laser diffraction (Ward
et al. 2009a). After skin incision and prior to lengthening,
gracilis and semitendinosus were identified. A small
segment of each muscle was atraumatically isolated by
blunt dissection. The custom clamp was then slipped
over the bundle, with care to prevent undue tension on
the muscle. The child’s leg was positioned with 90 deg
of hip flexion and 90 deg of knee flexion, and neutral
hip abduction–adduction, the clamp was engaged, and
the section of muscle within the jaws of the clamp was
re-sected and immediately placed in Formalin to fix the
biopsy specimen in its in vivo configuration. After 2 days of
fixation, muscle bundles were isolated on glass slides and
sarcomere length was measured by laser diffraction (see
below). For control patients receivingACL reconstruction,
hamstring muscles are not accessible in their in vivo
position, which precludes the use of the biopsy clamps
to obtain control values. Thus, for estimation of control
sarcomere lengths, we extracted these values from our
previous musculoskeletal model (Arnold et al. 2010).
Muscle mechanical testing
Biopsies for mechanics were stored in a glycerinated
relaxing solution overnight, composed of (mM):
potassium propionate (170.0), K3EGTA (5.0), MgCl2
(5.3), imidazole (10.0), Na2ATP (21.2), NaN3 (1.0),
glutathione (2.5), 50μM leupeptin, and 50% (v/v)
glycerol. For dissection of fibre or fibre bundle samples,
muscles were removed from storage solution and trans-
ferred to a relaxing solution at pCa 8.0 and pH 7.1
consisting of (mM): imidazole (59.4), KCH4O3S (86.0),
Ca(KCH4O3S)2 (0.13), Mg(KCH4O3S)2 (10.8), K3EGTA
(5.5), KH2PO4 (1.0), Na2ATP (5.1), and 50.0μM
leupeptin. Single fibre segments (1.5–3mm in length)
were carefully dissected and mounted in a chamber in
a custom apparatus at room temperature (20◦C). Fibres
were secured using 10-0monofilament nylon suture on
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one end to a force transducer (Model 405A, sensitivity
10 V g−1, Aurora Scientific, Ontario, Canada) and on
the other end to a titanium wire rigidly attached to a
rotational bearing (Newport MT-RS; Irvine, CA, USA;
Supplementary Fig. S1). Segments displaying obvious
abnormalities or discoloration were not used. The sample
was transillumated by a 7mW He–Ne laser to permit
sarcomere lengthmeasurement by laser diffraction (Lieber
et al. 1984). Resolution of this method is approximately
5 nm (Baskin et al. 1979). The system was calibrated
with a 2.50μm plastic blazed diffraction grating prior
to experimentation (Diffraction Gratings, Inc., Nashville,
TN, USA).
The fibre was brought to slack length, defined when
passive tension was just measurable above the noise
level of the force transducer. Sample dimensions were
measured optically with a cross-hair reticule mounted
on a dissecting microscope and micromanipulators on
an x–y mobile stage. The fibre was then loaded with
strains of approximately 0.25μm sarcomere−1 at 100 fibre
lengths s−1. Each stretch was held for 2 or 3min
during which stress relaxation was measured, before
a sequential stretch was made. Fibres were stretched
in total to approximately 100% strain and were saved
for titin analysis after mechanical testing. Force data
were converted to stress by dividing force by the base-
line cross-sectional area value determined assuming a
cylindrical sample with an average diameter determined
from three separate points along the fibre. Samples were
discarded if they did not produce a clear diffraction
pattern, if any irregularities appeared along their length
during testing, or if they were severed or slipped at either
suture attachment point during the test. Muscle bundles
were mechanically tested in the samemanner as fibres and
consisted of approximately 20 fibres and their constitutive
ECM.
Mechanical data analysis
All analysis was performed usingMatlab (Mathworks Inc.,
Natick,MA,USA). Relaxed stress after 2 or 3 minwas used
to fit a relaxed stress vs. sarcomere length curve. This curve
was fitted with a line for fibres, but with a quadratic for
bundles, as therewas notable non-linearity in bundle data.
For sample fits, sarcomere lengths below slack length are
assigned a stress of 0. This produces a ‘toe region’ due to
averaging of the fits across the range of slack sarcomere
lengths tested in fibres, generally below 2.5μm sarcomere
length. Only the data beyond the toe region in whichmost
fibres are generating tension are depicted (Fig. 2A and
C). Tangent modulus was calculated at given sarcomere
length by taking the derivative of the relaxed stress vs.
sarcomere lengthfit at that length.Comparisons of tangent
Figure 1. Images of biopsy collection
method using clamps for in vivo sarcomere
length determination
A, hamstring muscle is exposed. B, clamp is
secured around gracilis muscle with joint
position at 90 deg of hip and knee flexion.
C, close-up view of muscle clamps around the
biopsy tissue. D, biopsy is dissected from
muscle while clamped and fixed in Formalin for
subsequent sarcomere length measurement.
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stiffness were conducted with a three-way ANOVA for
pathology (CP vs. control), muscle (gracilis vs. semi-
tendinosus; repeatedmeasure), and scale (fibre vs. bundle;
repeated measure) with results considered significant at
P < 0.05. All data are presented in the text asmean± SEM
unless otherwise noted.
Protein gels
Titin isoform and MyHC content were analysed on gels
from both single fibres after mechanical experiments
and from sections of biopsies. Single fibres were stored
at −80◦C until analysed and boiled for 2 min in 10μl
sodiumdodecyl sulfate-vertical agarose gel electrophoresis
(SDS-VAGE) sample buffer (comprised of 8 M urea, 2 M
thiourea, 3%SDSw/v, 75mMdithiothreitol (DTT), 0.03%
bromophenolblue and0.05 MTris-Cl, pH6.8;Warren et al.
2003). For biopsies, a myofibril-rich fraction (∼10mgwet
weight) of individual biopsies (n= 24 biopsies from 12
patients for titin andMyHC) was homogenized in sample
buffer using the Bullet Blender (Next Advance, Inc., Averill
Park, NY, USA).
Figure 2. Passive tension as a function of sarcomere length for fibres and bundles, after stress relaxation
Plots represent the average of the fits from each individual sample ± SEM. The stress vs. sarcomere length fit was
linear for fibres with a R2 value of 0.962 ± 0.003 (A and B) and quadratic for bundles with a R2 value of
0.985 ± 0.002 (C and D). A, gracilis fibres show no difference between CP and control. B, semitendinosus fibres
show no difference between CP and control. C, CP gracilis bundles show a significant increase in stress at high
sarcomere lengths compared to control. D, CP semitendinosus bundles show a significant increase in stress at high
sarcomere lengths compared to control.∗ inside symbol designates the approximate sarcomere length at 90 deg
of hip and knee flexion.
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To quantify titin isoforms, the molecular mass of titin
in muscle samples was determined using SDS-VAGE. An
acrylamide plugwas placed at the bottomof the gel to hold
the agarose in place. The final composition of this plugwas
12.8% acrylamide, 10% v/v glycerol, 0.5 M Tris-Cl, 2.34%
N ,N ′-diallyltartardiamide, 0.028% ammoniumpersulfate
and 0.152% tetramethylethylenediamine (TEMED). The
composition of the agarose gel was 1% w/v SeaKem Gold
agarose (Lonza, Basel, Switzerland), 30% v/v glycerol,
50 mM Tris-base, 0.384 M glycine and 0.1% w/v sodium
dodecyl sulfate (SDS). Titin standards were obtained from
human cadaver soleus (3700 kDa) and rat cardiac muscle
(2992 kDa). The standard titinmolecularmasses are based
on sequence analysis of the 300 kb titin gene with a
coding sequence contained within 363 exons (Labeit &
Kolmerer, 1995; Freiburg et al. 2000). These tissues were
also homogenized and stored at −80◦C until analysis.
Before loading onto the gel, a titin standard ‘cocktail’
was created with the following ratio: 1 unit of human
soleus standard:3 units rat cardiac standard:6 units sample
buffer. Samplewellswere then loadedwithbothbiopsy and
rat cardiac homogenate. Human soleus and rat cardiac
titin homogenates were loaded into standard lanes. This
enabled titin quantification on each gel as previously
described (Warren et al. 2003). Gels were run at 4◦C for
5 h at 15mA constant current.
To quantify MyHC isoform distribution, homogenized
protein solutionwas resuspended to 0.125μgμl−1 protein
(BCA protein assay, Pierce, Rockford, IL, USA) in a
sample buffer consisting of DTT (100mmol l−1), SDS
(2%), Tris-base (80mmol l−1) pH 6.8, glycerol (10%)
and bromophenol blue (0.01% w/v). Samples were boiled
(2 min) and stored at −80◦C. Before loading onto the
gel, protein was further diluted 1:15 (0.008μgμl−1) in
the same sample buffer to account for the approximately
50-fold greater sensitivity of the silver stain. Ten micro-
litres of each sample were loaded in each lane. Total
acrylamide concentration was 4% and 8% in the stacking
and resolving gels, respectively (bisacrylamide, 1:50). Gels
(16 cm× 22 cm, 0.75mm thick) were run at a constant
current of 10mA for 1 h, and thereafter at constant
voltage of 275 V for 22 h at 4–6◦C. Gels were silver
stained (BioRad, Hercules, CA, USA). MyHC bands were
identified and quantified with densitometry (GS-800,
BioRad). The progression of the band was compared and
identified based on its relative molecular weight to that of
a human protein standard prepared (as described above)
fromanormal semitendinosusbiopsy that showedall three
human MHC bands (IIa, IIx and I).
Hydroxyproline content
Collagenpercentagewasdeterminedusing a colourimetric
analysis of hydroxyproline content. Briefly, muscle
samples were hydrolysed in 6 N HCl for 18 h, neutralized,
and samples were treated with a chloramine T solution
for 20min at room temperature followed by a solution
of p-diaminobenzaldehyde for 30min at 60◦C. Sample
absorbance was read at 550 nm in triplicate and
compared to a standard curve to determine the hydro-
xyproline content. Hydroxyproline content was converted
to collagen using a constant (7.46) that defines the
number of hydroxyproline residues in a molecule of
collagen.
Immunohistochemistry
Biopsies previously snap-frozen in isopentane were used
for immunohistochemistry. Cross-sections (10μm thick)
taken from themidportionof the tissue blockwere cut on a
cryostat at−25◦C (MicromHM500,Walldorf, Germany).
Serial sections were stained with haematoxylin–eosin to
observe general tissue morphology. To investigate ECM
components sections were labelled with primary anti-
bodies to fibrillar collagen type I (rabbit polyclonal,
Rockland, Gilbertsville, PA, USA) and laminin (rabbit
polyclonal, Sigma, StLouis,MI,USA).The secondary anti-
body used for visualization was an Alexa Fluor 594 goat
anti-rabbit immunoglobulinG (Invitrogen, Carlsbad, CA,
USA).
Fibre cross-sectional areas were measured from
laminin-stained slides using a custom-written macro in
ImageJ (NIH, Bethesda, MD, USA). Filtering criteria were
applied to insure measurement of actual muscle fibres.
These criteria rejected regions with areas below 50μm2
or above 5600μm2 to eliminate neurovascular structures
and ‘optically fused’ fibres, respectively. Fibres touching
the edge of the field were excluded as they were assumed
to be incomplete. Regions with circularity below 0.30 or
above 1.0 were excluded to prevent inclusion of fibres that
were obliquely sectioned.
Results
Passive mechanics
Passive mechanical properties were determined for three
fibres per muscle and two muscles per subject, for both
control children (n= 14) and children with CP (n= 17).
Fibre diameter was smaller for CP (66.3± 2.6μm) than
for control (80.2± 2.6μm; P < 0.001) as previously
described (Fride´n & Lieber, 2003). Slack sarcomere length
for control (2.31± 0.04μm) fibres was not significantly
different from CP (2.31± 0.04μm (SD); P > 0.9) fibres.
The stiffness of CP fibres was not significantly different
from control for gracilis (control 21.5± 1.8 kPaμm−1; CP
21.5± 2.4 kPaμm−1; Figs 2A and 3A) or semitendinosus
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(control 22.4± 1.8 kPaμm−1; CP 23.6± 1.7 kPaμm−1;
Figs 2B and 3A), nor was it significantly different between
muscles.
Passive mechanical properties were determined for
three bundles on the samebiopsy as for fibres. Fibre bundle
diameters were not significantly different between control
(366.1± 15.0μm) and CP (354.9± 15.2μm; P > 0.4)
bundles, nor were slack sarcomere lengths (control:
2.27± 0.03μm; CP 2.29± 0.03μm; P > 0.5). CP
bundles had higher stresses at longer sarcomere lengths
for both gracilis and semitendinosus muscle. When
comparing the tangent stiffness at 4.0μm the stiffness
of CP bundles was significantly greater than control
(P < 0.05) for both gracilis (control 36.1± 3.9 kPaμm−1;
CP 60.4± 11.8 kPaμm−1; Figs 2C and 3B) and
semitendinosus (control 25.2± 2.9 kPaμm−1; CP
40.7± 4.9 kPaμm−1; Figs 2D and 3B).
The three-way ANOVA with muscle (semitendinosus/
gracilis; repeated measure), scale (fibre/bundle; repeated
measure) and condition (CP/control) on tangent stiffness
revealed a main effect of all three independent measures
(P < 0.05 for condition and muscle; P < 0.001 scale).
The results also showed a significant interaction between
muscle and scale (P < 0.05), with post hoc tests revealing
gracilis bundles are stiffer than semitendinosus, and a
significant interaction of condition and scale, with post hoc
tests revealing an effect of CP only at the bundle level for
semitendinosus (P < 0.05).
To determine whether the mechanical changes were
related to the clinical observations made on the patients,
stiffness was correlated with clinical severity score. There
was no significant correlation between stiffness and either
Gross Motor Function Classification System or popliteal
angle at either the fibre or bundle level (Supplemental
Fig. 2A). To determine consistency within patients, a
correlation was run between gracilis and semitendinosus
stiffness within the same patient, or fibre stiffness to
bundle stiffness within the same biopsy, but again there
were no significant correlations (Supplemental Fig. 2B and
C). There was also a concern that there might be an
age effect since the control subjects were slightly older
than CP subjects (Table 1) but no significant correlation
was found, validating the comparison of control to
CP subjects with different ages (Supplemental Fig. 2D).
Further, the mechanics were compared from patients who
underwent a previous hamstring lengthening surgery or
botulinum toxin injection prior to biopsy as these may
affect stiffness. No significant difference was observed for
prior botulinum toxin injection for bundles (P > 0.3)
or fibres (P > 0.8). Only one patient with mechanics
measured had undergone a previous lengthening surgery,
which was not an outlier among any mechanical
measure.
Figure 3. Tangent stiffness of fibres and bundles
Samples are represented with either a linear fit for fibres or a
quadratic fit for bundles. A, tangent stiffness values at 4.0 μm for
single fibres are not changed with CP for either gracilis or
semitendinosus muscles. B, tangent stiffness values at 4.0 μm for
fibre bundles are significantly greater in CP compared to control
bundles in both gracilis and semitendinosus (P < 0.05). C, tangent
stiffness values at measured average in vivo sarcomere length for CP
bundles or the predicted in vivo sarcomere length for control
bundles show highly elevated values in CP for a joint configuration
of 90 deg hip and knee flexion.
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In vivo sarcomere lengths
In vivo sarcomere length from cerebral palsy patients
of contractured hamstring muscles (n= 22) was
3.54± .14μm for gracilis and 3.62± .13μm for semi-
tendinosus at 90 deg of hip and knee flexion. For control
comparison, model results were used as described in
Methods (Arnold et al. 2010). Both gracilis and semi-
tendinosus had significantly longer sarcomere lengths at
90 deg of hip and knee flexion than predicted by themodel
by about 0.5μm (Fig. 4A, P < 0.05 for semitendinosus
and gracilis). Combining the sarcomere length values
with passive mechanical properties demonstrates that CP
muscle tissue at these joint angles bears a higher passive
load compared to control muscle (Fig. 3C).
To determine whether the sarcomere length was
associated with functional changes, clinical measures were
correlated to sarcomere length. There was a significant
correlation between in vivo sarcomere length and both
Gross Motor Function Classification System (P < 0.05)
and sarcomere length (P < 0.05), indicating that more
severely involved patients had longer in vivo sarcomere
lengths (Fig. 4B). There was also a significant negative
correlation between popliteal angle and in vivo sarcomere
length indicating that longer sarcomere lengths were
present in joints with more severe contractures (Fig. 4C).
Together these correlations provide further evidence that
in vivo sarcomere lengths are elevated in CP.
To compare predicted in vivo stiffness of CP muscles
compared to controlwe also evaluated the tangent stiffness
at the average in vivo sarcomere length of 90 deg of hip and
knee flexion for each muscle and condition from the data
above. Combining the in vivo sarcomere lengths with the
mechanical data shows that in vivo stiffness is predicted
to be much larger for CP muscle (Fig. 3C). As fibres had
linear stress–strain relationships, the tangent stiffness does
not vary with sarcomere length and is thus the same result
as the tangent stiffness at 4.0μm.
Titin isoforms
To determine if titin size was related to overall muscle
stiffness we measured titin molecular mass from a biopsy.
The results of a two-way ANOVA showed no significant
difference (P > 0.05) for CP with mean values of gracilis
(control 3588± 18 kDa; CP 3667± 22 kDa) and semi-
tendinosus (control 3625± 19 kDa; CP 3658± 26 kDa;
Fig. 5) among the samplesmeasured (n= 24, 6 permuscle
condition). The mass of CP titin was actually larger than
that of control suggesting, if anything, a more compliant
isoform and unable to account for any increased passive
stiffness of the muscle as a whole.
The effect of titin isoformwas also investigated on single
fibres that had previously undergone passive mechanical
testing. A two-way ANOVA showed no significant
difference (P > 0.1) between titin isoform sizes for gracilis
(control 3758± 24 kDa; CP 3772± 36 kDa) or semi-
tendinosus (control 3729± 40 kDa; CP 3797± 40 kDa)
among the single fibres measured (n= 55). CP fibres
having equivalent titin isoform size to control fibres is
consistent with the fact that CP and control fibres have
equivalent stiffness. The effect of titin isoform size on
the variability in mechanical stiffness of fibres was also
investigated, but there was not a significant correlation
between titin size and fibre stiffness within single fibres
Figure 4. In vivo sarcomere length of gracilis and semitendinosus
A, measured in vivo sarcomere length with 90 deg of hip and knee flexion ± SEM for CP subjects in gracilis
and semitindenosus (P < 0.05). Solid white line represents predicted sarcomere length for control children.
B, correlation between in vivo sarcomere length measured for CP subjects and their Gross Motor Function
Classification System (GMFCS) shows a positive significant correlation (P < 0.05), meaning subjects with longer in
vivo sarcomeres are more severely affected patients. C, correlation between in vivo sarcomere length and popliteal
angle is negative and significant (P < 0.05), meaning subjects with less knee extension have longer sarcomere
lengths.
C© 2011 The Authors. Journal compilation C© 2011 The Physiological Society
J Physiol 589.10 Passive mechanical properties of muscle contracture 2633
(Supplemental Fig. S3). The molecular masses are larger
for single fibres than for the whole biopsies, possibly due
to modified preparation methods.
Collagen content
Collagen content of the biopsies was measured (n= 40,
10 per muscle per condition) as collagen is thought
to be the primary load-bearing structure of the
ECM within muscle (Purslow, 1989). CP muscles
had significantly higher collagen concentrations in
both gracilis (control 8.0± 1.6μg (mg wet weight)−1);
CP 11.2± 2.6μg (mg wet weight)−1) and semi-
tendinosus (control 4.0± 0.3μg (mg wet weight)−1);
CP 8.8± 0.8μg (mg wet weight)−1) as determined by
a two-way ANOVA on muscle and condition (Fig. 6,
P < 0.05). Collagen content was elevated in both
gracilis and semitendinosus, although post hoc tests
revealed a significant difference only in semitendinosus
(P < 0.001). Gracilis also tended to have higher collagen
concentrations corresponding to the relationship seen in
passive bundle stiffness. The collagen content was not
significantly different for patients who underwent a pre-
vious lengthening surgery (P > 0.5) or botulinum toxin
injections (P > 0.8) prior to biopsy.
Collagenwas also visualized by immunohistochemistry.
Qualitative results show an increase in fibrillar collagen
type I (Fig. 7A–D) in muscle from children with CP,
corresponding the hydroxyproline results. There was
no apparent mislocalization of collagen; however, an
increased frequency of large collagen deposits was
observed. Laminin, a component of the basal lamina,
also showed marked increase in CP muscle (Fig. 7E–H).
These results demonstrate an increase of ECM material
Figure 5. Molecular mass of titin isoforms of CP and control
subjects in gracilis and semitendinosus muscles
Two-way ANOVA shows no significant effect of pathology on
molecular mass (P > 0.05). Although not significant, the trend for
molecular mass of titin in CP muscles is larger than control
suggesting, if anything, more compliant fibres due to titin
alterations.
that includes, but is not limited to collagen. While
histological evidence shows an increase in ECM material
in muscle from children with cerebral palsy, there is also
a corresponding decrease in fibre cross-sectional area
(from 3141± 375μm2 for controls to 1255± 226μm2;
P < 0.001 for cerebral palsy) as has been previously
reported (Fride´n & Lieber, 2003).
Myosin heavy chain
To determine whether any of the single mechanical fibre
data might be confounded by systematic differences in
muscle fibre type between patient populations, myosin
heavy chain isoformcontentwasmeasured (n= 35fibres).
One-way ANOVA comparing tangent stiffness of different
fibre types did not produce a significant result for either
CP or control fibres (P > 0.05; Supplemental Fig. S4).
To determine the distribution of different fibre types for
hamstring muscles in CP myosin heavy chain content was
measured from a sample of biopsies (n= 24, 6 per muscle
per condition). CP muscles had increased slow myosin
heavy chain expression (gracilis – control 29.3± 1.9% to
CP 40.0± 2.5%; semitendinosus – control 29.7± 1.7%
to CP 41.0± 3.3%; P < 0.001; Fig. 8), but there was no
significant change in either of the fast isoforms measured
(IIa or IIx). Since myosin heavy chain is the primary
determinant of fibre type, these results demonstrate a shift
to slower fibres in CP muscle. There was no significant
difference between gracilis and semitendinosus muscles.
Discussion
The most significant finding of this study is that muscle
tissue from children with CP is significantly stiffer
compared to typically developing children. This increased
Figure 6. Collagen content of muscle biopsies shows
significantly higher collagen content in CP biopsies
The results of this assay are consistent with the increased stiffness
observed in fibre bundles (Fig. 4). ∗indicates a significant post hoc
difference between control and CP for the semintendinosus
(p < 001).
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Figure 7. Immunohistochemistry of muscle
biopsies show qualitatively increased levels of
ECM in CP (B, D, F and H) compared to control (A,
C, E and G) children
Representative images with primary antibody to fibrillar
collagen type I in cross section (A and B) and
longitudinal section (C and D). Representative images
with primary antibody to laminin of the basal lamina, in
cross section (E and F) and longitudinal section (G and
H). Note that muscle fibers from children with CP are
slightly smaller with a great amount of Collagen I and
laminin, two of the major components of the
extracellular matrix. Scale bars represent 100 μm.
Figure 8. Myosin heavy chain isoforms
There was a significant increase in myosin heavy chain I
in CP muscles compared to control suggesting
contractured fibres have a slower phenotype. There was
no significant difference between muscles. ∗represents
significant difference in MyHC 1 percentage between
control and CP muscles (p < 0.001)
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passive stiffness is accompanied by an increase in collagen
content and is made even more functionally significant in
that in vivo sarcomere length of CP hamstring muscles is
significantly longer compared to predictions for control
children. Taken together, these data provide a mechanistic
explanation for the increased joint and muscle stiffness
observed in these contracture patients.While fibre bundles
were different between CP and control muscle, we found
no significant difference in mechanical properties at the
single fibre level of muscle and no change in titin isoform
size. Thus, we conclude that, for human hamstring
muscles, increased passive tension in contracture is due to
a change in ECM stiffness and increased in vivo functional
sarcomere length rather than any intracellular alteration.
Bundle mechanics
While fibres contribute to passive tension of muscle,
muscle ECMplays an important role in passivemechanics,
especially at longer sarcomere lengths. The results show a
significant increase in the tangent stiffness of fibre bundles
from CP patients. While fibres were fitted well with a
linear stress–sarcomere length relationship, fibre bundles
required a non-linear quadratic fit. This non-linearity
results in similar tissue stiffness at small strains, but
significantly increased stiffness at long sarcomere lengths
of the CP muscle tissue. Muscle contractures often limit
joint range of motion suggesting that there are large
in vivo strains on the muscle. We thus believe that,
in vivo, the ECM bears a large portion of the passive
muscle load.
Collagen is considered the primary load-bearing
structure within muscle ECM (Purslow, 1989). We hypo-
thesized that an increase in collagen content of CP
muscle could lead to the increased passive stiffness seen
in bundles. Using a hydroxyproline assay to test the
hypothesis, the results demonstrate a significant increase
in collagen within CP muscle. Although these data are
presented in micrograms of collagen per milligram of
muscle wet weight, they are similar to previous data
presenting collagen as a percent of dry weight (Bendall,
1967), using the assumption that muscle is approximately
80% water (Ward & Lieber, 2005). Increased collagen
was also observed by immunohistochemistry along with
another ECM component, laminin, a critical component
for cellular attachment to the basal lamina. These results
are in agreement with a previous study showing increased
collagen content within CP muscle (Booth et al. 2001).
Many additional factors may be playing a role in the
increased ECM stiffness. The organization of collagen,
the distribution of collagen types, or the proteoglycan
content all could be altered in CP to create a stiffer ECM
and represent areas of further investigation. Immuno-
histochemistry of other muscle proteins (α-actinin,
desmin, dystrophin) revealed no obvious differences
between patient groups.
One previous study investigated the mechanics of
fibre bundles from contractured muscle tissue (Lieber
et al. 2003). Despite finding stiffer fibres we found more
compliant bundles in CP muscle. This result is difficult
to reconcile with the increased passive stiffness of the
whole muscle that has been reported. The previous study
was conducted on biopsies taken from various muscles
that were not matched between populations, which could
account for some of these differences and all muscles were
from upper extremities, which may respond differently
to spasticity. In addition, the ECM from upper extremity
muscles was highly deranged in the contractured muscles
(see Fig. 2 of Lieber et al. 2003) making area fraction
measurements from these specimens difficult. It is possible
that the area fraction of ECMwas overestimated, resulting
in artificially low values for bundle modulus. Finally, the
non-linear behaviour of upper extremity muscles was
quantified by only fitting data to the linear portion of
the sarcomere length–stress curve. The current method
represents a more accurate method for handling analysis
of the non-linear relationships.
Sarcomere organization
Sarcomere length operating ranges of semitendinosus
and gracilis muscles are unknown, although muscles
are typically believed to operate on the plateau of the
length–tension curve (2.5–2.7μm for human skeletal
muscle; Walker & Schrodt, 1974). A previous study
demonstrated that spastic muscle operates at longer
sarcomere lengths than control (Lieber & Fride´n, 2002),
which would lead to a larger observed passive stiffness
such as that seen in contracture. We measured in vivo
sarcomere lengths of patients with CP at a defined joint
angle and compared these values to sarcomere lengths
of control subjects that were calculated based on in vivo
sarcomere lengths, moment arms and muscle–tendon
lengths (Arnold et al. 2010). The results showed that the
CP sarcomere lengths are significantly longer than those
predicted from the model. The lengths measured were
also much longer than optimal sarcomere length, lending
further evidence to the idea that they are overly stretched in
contracture. With CP subjects operating at longer lengths
of the passive length–tension relationship, this means that
the muscle is experiencing higher stresses not only due to
material property changes, but also due to this shift along
the passive length–tension curve. This difference becomes
more pronounced as the knee extends and the hip flexes,
and may limit range of motion for children with contrac-
tures.
It is often stated that muscle adds or subtracts serial
sarcomeres to optimal sarcomere length in vivo (Williams
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& Goldspink, 1973). Long in vivo sarcomeres suggest
an inability of the muscle to add sarcomeres in series,
which would be exacerbated during growth spurts, which
have been associated with the onset of muscle contra-
ctures (Janice & Alwyn, 2005). The very long sarcomere
lengths observed in vivo clearly imply that muscles from
children with CP are under high stress. The source of
the force that creates or opposes this stress is not known.
However, we have speculated, based on analysis of the
transcriptome, that muscles from children with CP are
unable to grow serially in response to the stretch imposed
by osteogenesis (Smith et al. 2009). It is also possible that
muscles would decrease their serial sarcomere number,
which would provide a resistive force since the changes
could be slow and accompanied by reinforcement of
the muscle fibre by the ECM. Muscle contracture is
often described as a ‘shortened’ muscle; our finding of
increased in vivo sarcomere length corresponds with the
notion that muscle shortening is derived from fewer series
sarcomeres, not shortened sarcomeres. Longer in vivo
sarcomere lengths are an important factor for both passive
and active force production of skeletal muscle. Previous
research has demonstrated that muscles from children
with CP are smaller than those of control children, yet
muscle force production is reduced to an even greater
extent indicating a dysfunction of active muscle force
production in CP (Elder et al. 2003; Moreau et al. 2010).
A consequence of having longer in vivo sarcomere lengths
for children with CP is the muscle will be working at
different portions along its active length–tension curve
(Gordon et al. 1966) compared to control subjects. Based
on measured human filament lengths (Walker & Schrodt,
1974) and the increase in ∼0.5μm sarcomere length, the
decrease in force from a typically developing child on the
plateau of the length–tension curve to a child with CP
on the descending limb would be 33%. It is interesting
to note that this is on the same scale as the reduction in
force that is not accounted for by decreased muscle size in
these patients (Elder et al. 2003;Moreau et al. 2010). Thus,
perhaps altered in vivo sarcomere length operating range
represents a significant functional alteration in muscles
from children CP and demonstrates that thesemuscles are
not simply changing sarcomere number to ‘re-optimize’
the muscle after injury.
Potential mechanisms of contracture formation
It is possible that the changes inECMand in vivo sarcomere
length take place simultaneously and independently, or
that one precedes and directly affects the other. If these
two alterations of CP muscle are not causal, they could be
a consequence of the same factors within spastic muscle.
Previous research showed that myostatin, a negative
regulator of muscle growth, also stimulates proliferation
of muscle fibroblasts and the release of ECM proteins (Li
et al. 2008). Myostatin mRNA has also been shown as
significantly increased inCPmuscle of theupper extremity
(Smith et al. 2009). Alternatively, transforming growth
factor-β1 has been shown to induce a shift in satellite
cells from amyogenic lineage to fibrobasts (Li et al. 2004).
This process also has the potential to limit growth through
satellite cell depletion and increase the ECM secreting cell
population.
Longer in vivo sarcomeres of CP muscles demonstrate
that there is increased sarcomere strain, which has been
shown to directly induce skeletal muscle injury (Patel
et al. 2004). Repeated strain-induced injuries have been
shown to drastically increase collagen content and fibrosis
in skeletal muscle (Stauber, 2004). The effects of chronic
strain injuries persist for months or even years and
could be responsible for the effects of muscle in contra-
cture. Repeated strain-induced injury also results in lower
force-producing capacity of muscle, which may provide
another explanation for the reduced specific tension of
CP muscle (Proske & Morgan, 2001). The increased
fibrosis and stiffness of muscle contracture could also be a
compensatory mechanism to limit further strain-induced
injury.
There is also potential for a fibrosis induced from
spasticity to lead directly to a limitation of longitudinal
growth. Satellite cells responsible for muscle growth rely
on migration across the basement membrane during
activation with the release of matrix metalloproteases
(Chen & Li, 2009). Skeletal muscle fibrosis could impede
muscle regeneration by forming a mechanical barrier to
this process (Chen & Li, 2009). Stem cell differentiation is
also sensitive to the elasticity of the matrix in which it is
embedded (Engler et al. 2006). Our study demonstrated
an altered stiffness of the ECM in contracture tissue that
could lead to an inhibition of satellite cell activation or
proliferation (Boonen et al. 2009; Gilbert et al. 2010) and
perhaps even predispose muscle stem cells to differentiate
toward the fibroblast lineage. It is also possible that fibrosis
and lack of growth create a vicious cycle that leads to
muscle contracture.
Titin isoforms
Since titin isoform size is related to muscle passive tension
(Prado et al. 2005), we hypothesized that shorter titin
isoforms would be present in muscle contracture leading
to increased stiffness. However, our results show no
difference in titin size between CP and control muscles.
Thus, we conclude that titin is not altered in CP to cause
contracture, at least not in a manner that alters size. Titin
isoform changes have been reported in cardiac disease
(Neagoe et al.2003), but literature on titin isoformchanges
in skeletal muscle is sparse. A previous study investigating
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titin isoform in spastic muscles of stroke patients also
found no change in isoform size (Olsson et al. 2006).
Fibre mechanics
While titin isoform size contributes to single fibre
mechanics, other proteins or organization of fibrematerial
could be responsible for an increased passive tension at
the cellular level. Two previous studies did demonstrate
stiffermuscle fibres for spastic patients. These studies each
had important differences, however. In one the muscle
fibres tested were from a range of muscles which was
not the same in the spastic and control groups (Friden
& Lieber, 2003). This is a confounding issue because it
is known that different muscles have different passive
mechanical properties (Prado et al.2005).Another showed
increased stiffness only in fast fibres with an increase in
the proportion of fast fibres (Olsson et al. 2006). We
did not see a corresponding shift to fast fibres of our
muscles, and in fact showed a significant increase in type
I myosin heavy chain of CP muscles indicating a shift to
slower fibres (Fig. 8). Overall, previous studies have shown
disagreement on whether spastic muscles gain a faster or
slower phenotype, which could bemuscle specific (Brooke
& Engel, 1969; Scelsi et al. 1984; Jakobsson et al. 1991).
However, the most straightforward interpretation of our
data is that over-activity resulting from spasticity drives
a shift to slower fibres. It is also important to note that
the previous study was performed with vastus lateralis
muscle biopsies (Olsson et al. 2006), which show much
less spasticity and contracture development compared
to the medial hamstrings studied here (Damiano et al.
2002; Pierce et al. 2008). Future studies across a wider
range of muscles are required to ultimately resolve these
ambiguities.
Study limitations
One important limitation of this study is the subject
heterogeneity. CP is a spectrum disorder and here we
have primarily examined only the commonly shared
parameters of this range of subjects with spastic CP.
A more detailed analysis could be attempted using
patient stratification by clinical parameters, Gross Motor
Function Classification System, popliteal angle, limbs
affected, age and treatment regimens. However, due to
limitations of the sample size and the high variability
of parameters in working with human subjects, this was
not possible. We were able to demonstrate a significant
correlation between severity measures and sarcomere
length,which helped tomitigate the fact thatwe are relying
on model data for our comparison with in vivo sarcomere
lengths control children.
The source of controls for this study is not ideal
since the patients had sustained an ACL tear. However,
these patients were several months removed from the
injury and had normal mobility at the time of surgery.
Our approach represents the best available source of
normal hamstring muscle from a pediatric population.
These subject groups were not perfectly age-matched,
although they all came from a pediatric population, as
ACL surgeries do not occur prior to the teenage years
whereas hamstring-lengthening surgeries often occur
much earlier. However, our passive mechanical data did
not correlate with age, suggesting that these small age
discrepancies did not affect our outcomes. The subjects
also underwent varied previous treatments, of which
previous hamstring-lengthening surgery and botulinum
toxin injections into the hamstrings was tracked. These
variableswere analysed in relation tomechanicalmeasures
and collagen content, but no relationship was found.
These treatment effects are further complicated by highly
variable times since treatment.
Summary
It is known thatmuscle contractures result from the UMN
lesion in CP. Here, using a larger and more controlled
study then previous ones, we showed increased passive
stiffness of fibre bundles and increased sarcomere length in
vivo. Together, these properties create a muscle in CP that
experiences much higher stresses with increasing muscle
length and clearly contributes to the development of
muscle and joint contractures. Future studies are required
to understand the mechanistic basis for the sarcomere
length change and increased ECM content in CP as these
clearly represent targets for therapy.
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